Kettner H

Department of Neurology, Carhart-Harris Lab, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.

Kettner H

On the meaning of "plasticity" in neuroscience and mental health research and its relation to the action of psychedelic therapy.

Tales of the unexpected: psychedelic trial design solutions

Well-being as a primary endpoint in clinical trials: a call for consensus.

Correction to: Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.

On the meaning of ‘plasticity’ in neuroscience and mental health research and its relation to the action of psychedelic therapy

Human brain changes after first psilocybin use.

Effects of psychedelic use on authoritarian attitudes revisited.

Baseline Mood and "Relational Triad" Predict Acute Qualities of Psychedelic Experience.

Exploring the potential psychological predictors associated with changes in depression, anxiety, and well-being following naturalistic psychedelic use.

Validation of the Imperial Psychedelic Predictor Scale - CORRIGENDUM.

Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion

Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat.

Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings.

A Scoping Review of Research in Naturalistic Studies with Psychedelics.

Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies.

Prediction of hallucinogen persisting perception disorder and thought disturbance symptoms following psychedelic use.

Dynamic medial parietal and hippocampal deactivations under DMT relate to sympathetic output and altered sense of time, space, and the self.

From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS).

Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.

Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey study.

Human brain changes after first psilocybin use

Validation of the imperial psychedelic predictor scale.

Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy.

Psychological effects of psychedelics in adolescents.

Effects of Psychedelics in Older Adults: A Prospective Cohort Study.

Long-term benefits to psychological health and well-being after ceremonial use of Ayahuasca in Middle Eastern and North African immigrants and refugees.

Psychiatric risks for worsened mental health after psychedelic use.

The Relationship Between Changes in Mindfulness and Subsequent Changes in Well-Being Following Psychedelic Use: Prospective Cohort Study.

Dynamic medial parietal and hippocampal deactivations under DMT relate to sympathetic output and altered sense of time, space, and the self

Psychedelics and sexual functioning: a mixed-methods study.

Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study.

Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder.

Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences.

Human brain effects of DMT assessed via EEG-fMRI.

Canalization and plasticity in psychopathology.

Predictors Of Hallucinogen Persisting Perception Disorder Symptoms, Delusional Ideation And Magical Thinking Following Naturalistic Psychedelic Use

Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.

The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.

Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.

Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.

Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience.

Psychedelics alter metaphysical beliefs.

Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey.

Turn on, Tune in, and Drop out: Predictors of Attrition in a Prospective Observational Cohort Study on Psychedelic Use.

Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample.

Psychedelics and health behaviour change.

Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?

Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness.

Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing.

Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation.

From Egoism to Ecoism: Psychedelics Increase Nature Relatedness in a State-Mediated and Context-Dependent Manner.

Predicting Responses to Psychedelics: A Prospective Study.